Key result
Adipose dysfunction, RAAS activation, and microvascular impairment drive obesity-associated hypertension.
Why the study?
There are many hypothetical mechanisms to explain obesity-associated hypertension, with a need to clarify the role of adipose tissue and inflammation in its pathogenesis.
This review summarizes the pathophysiological mechanisms linking obesity to hypertension, emphasizing the roles of adipose tissue RAAS activation, inflammation, and microvascular dysfunction.
Adipose RAAS may drive obesity hypertension; leaves open targeted interventions pending prospective validation.
With excess nutrition, the burden of obesity is a growing problem worldwide. The imbalance between energy intake and expenditure leads to variable disorders as all major risk factors for cardiovascular disease. There are many hypothetical mechanisms to explain obesity-associated hypertension. Activation of the RAAS is a key contributing factor in obesity. Particularly, the RAAS in adipose tissue plays a crucial role in adipose tissue dysfunction and obesity-induced inflammation. The phenotypic changes of adipocytes occur into hypertrophy and an inflammatory response in an autocrine and paracrine manner to impair adipocyte function, including insulin signaling pathway. Adipose tissue produce and secretes several molecules such as leptin, resistin, adiponectin, and visfatin, as well as cytokines such as TNF-α, IL-6, MCP-1, and IL-1. These adipokines are stimulated via the intracellular signaling pathways that regulate inflammation of adipose tissue. Inflammation and oxidative stress in adipose tissue are important to interact with the microvascular endothelium in the mechanisms of obesity-associated hypertension. Increased microvascular resistance raises blood pressure. Therefore, a regulatory link between microvascular and perivascular adipose tissue inflammation and adipokine synthesis are provided to explain the mechanism of obesity-associated hypertension.
No takes yet. Share an insight, caveat, or question.
Young Sun Kang (2013) conducted a review in Obesity-associated hypertension. Obesity-associated hypertension is driven by complex mechanisms including adipose tissue dysfunction, activation of the renin-angiotensin-aldosterone system, and microvascular endothelial dysfunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: